stars 1 stars 2 stars 3

Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear. We are committed to this mission and a strategy that is grounded upon time and cost-efficient drug development to deliver safe and effective therapies to patients. Lumos Pharma’s clinical development program will initially focus on its lead product candidate LUM-201, an oral growth hormone stimulating therapeutic in clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an alternative to the injections that current PGHD patients endure for many years of treatment. As a key component of our mission, Lumos Pharma is actively seeking strategic partnerships to expand its portfolio of rare disease therapeutic candidates. We leverage our experience, knowledge, and stakeholder collaborations to identify and acquire or in-license novel products for development and commercialization. Driven by a sense of commitment to patients, their families, and the broader community impacted by rare diseases, we seek to be a leading provider of innovative medications that address a multitude of rare diseases.

View Top Employees from Lumos Pharma
Ticker LUMO
Revenue $2 million
Employees 40 (39 on RocketReach)
Founded 1999
Address 4200 Marathon Blvd, Austin, Texas 78756, US
Phone (512) 215-2630
Fax (515) 296-5557
JavaScript, HTML, PHP +36 more (view full list)
Category Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Clinical Trials, Health Care
Web Rank 14 Million
Keywords alafair biosciences, inc, lumis pharma, vigilan lumos, lumos pharma
Competitors Concert Pharmaceuticals, Inc., KBP Biosciences, Otonomy, Inc, Precision Biologics, Soligenix, Inc.
SIC 283, 80, 873, 28, 87
NAICS 54171, 325, 54, 541711, 541, 32, 5417

Lumos Pharma Questions

The Lumos Pharma annual revenue was $2 million in 2023.

Rick Hawkins is the President and Chief Executive Officer of Lumos Pharma.

39 people are employed at Lumos Pharma.

Lumos Pharma is based in Austin, Texas.

The NAICS codes for Lumos Pharma are [54171, 325, 54, 541711, 541, 32, 5417].

The SIC codes for Lumos Pharma are [283, 80, 873, 28, 87].

Top Lumos Pharma Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users